This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
UnitedHealth Group, Inc. is the largest health care services company in the world, serving over 50 million individuals in the United States as of 2019 and over 5 million internationally. The company provides a wide range of health care products and services, such as health maintenance organizations (HMOs), point of service plans (POS), preferred provider organizations (PPOs), and managed fee-for-service programs. UnitedHealth has the largest and most diverse membership base within the managed-care organization market, which gives it significant competitive advantages. It also has built its prescription drug business through OptumRx division, with the acquisition of Catamaran in 2015.
UnitedHealth (UNH) Up 3.6% Since Earnings Report: Can It Continue?
by Zacks Equity Research
UnitedHealth (UNH) reported earnings a month ago. What's next for the stock? We take a look at earnings estimates for some clues.
Ensign Group (ENSG) Q3 Earnings Miss Estimates, Rise Y/Y
by Zacks Equity Research
Ensign Group's (ENSG) earnings missed estimates in Q3 but grew year over year due to higher revenues.
Humana (HUM) Beats Q3 Earnings Estimates, Revenues Miss
by Zacks Equity Research
Humana's (HUM) strong third-quarter earnings were driven by significantly low share count.
Can Retail Segment Further Drive Humana's (HUM) Q3 Earnings?
by Zacks Equity Research
Humana's (HUM) third-quarter results are likely to be driven by strong performance of its Retail segment.
Molina Healthcare (MOH) Q3 Earnings Beat Estimates, Up Y/Y
by Zacks Equity Research
Molina Healthcare's (MOH) third-quarter earnings were driven by solid revenue growth.
Community Health (CYH) Incurs Wider-Than-Expected Loss in Q3
by Zacks Equity Research
Community Health's (CYH) third-quarter loss was wider than expected due to huge cat loss.
Teladoc (TDOC) Q3 Loss Wider Than Expected, Revenues Top
by Zacks Equity Research
Teladoc's (TDOC) third-quarter revenues grew year over year on higher visits.
Envision Healthcare's (EVHC) Q3 Earnings Miss Expectations
by Zacks Equity Research
Envision Healthcare's (EVHC) third-quarter results were adversely impacted by hurricanes Harvey and Irma.
WellCare Health's (WCG) Q3 Earnings Beat Estimates, Up Y/Y
by Zacks Equity Research
WellCare Health's (WCG) third-quarter results were driven by membership growth.
Aetna (AET) Tops Q3 Earnings Estimates, Raises 2017 Guidance
by Zacks Equity Research
Aetna's (AET) solid third-quarter results were largely driven by continued strong performance in the company's Health Care segment.
LifePoint Health's (LPNT) Q3 Earnings and Revenues Miss
by Zacks Equity Research
LifePoint Health's (LPNT) third-quarter earnings missed estimates and declined year over year owing to lower revenues.
Universal Health (UHS) Q3 Earnings, Revenues Lag Estimates
by Zacks Equity Research
Universal Health's (UHS) third-quarter earnings were driven by solid revenue growth.
Acadia Healthcare (ACHC) Q3 Earnings, Revenues Lag Estimates
by Zacks Equity Research
Acadia Healthcare's (ACHC) third-quarter earnings reflect better performance in its U.S. operations in spite off catastrophe losses playing spoilsport.
Anthem's (ANTM) Q3 Earnings Beat Estimates, Improve Y/Y
by Zacks Equity Research
Anthem's (ANTM) strong third-quarter results were driven by solid enrollment growth.
Centene (CNC) Tops Q3 Earnings & Revenues, Raises '17 View
by Zacks Equity Research
Centene's (CNC) strong third-quarter earnings were driven by solid revenue growth.
Zacks.com featured highlights: Huntington Ingalls Industries, KB Home, Big Lots, UnitedHealth Group and ON Semiconductor
by Zacks Equity Research
Zacks.com featured highlights: Huntington Ingalls Industries, KB Home, Big Lots, UnitedHealth Group and ON Semiconductor
These 5 Stocks Flaunt Impressive Interest Coverage Ratio
by Zacks Equity Research
Interest expense has a direct bearing on the profitability of a company and its creditworthiness depends on how effectively it meets interest obligations.
Top Ranked Momentum Stocks to Buy for October 23rd
by Zacks Equity Research
Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, October 23rd:
Top Research Reports for UnitedHealth, Goldman Sachs & Morgan Stanley
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including UnitedHealth (UNH), Goldman Sachs (GS) and Morgan Stanley (MS).
Humana Expands MA Offerings, Increases Benefits for Members
by Zacks Equity Research
Humana (HUM) continues to expand and restructure its Medicare Advantage plans in order to enhance the reach and quality of its offerings across the world.
UnitedHealth (UNH) Catches Eye: Stock Jumps 5.5%
by Zacks Equity Research
UnitedHealth (UNH) shares rose nearly 6% in the last trading session, amid huge volumes.
UnitedHealth (UNH) Beats Q3 Earnings on Higher Membership
by Zacks Equity Research
UnitedHealth (UNH) beats earnings in the third quarter driven by higher contribution from both its segments.
UnitedHealth (UNH) Beats on Q3 Earnings, Guides Higher
by Zacks Equity Research
UnitedHealth (UNH) beat earnings estimates in third quarter driven by higher contribution from both of its segments
Is a Surprise Coming for UnitedHealth Group (UNH) This Earnings Season?
by Zacks Equity Research
UnitedHealth Group (UNH) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP.
4 HMOS for Gains Amid Constant Regulatory Chaos
by Zacks Equity Research
Despite the continuing chaos and insecurity storming the health care space with respect to repeal and replace of the old order, these healthcare stocks look solid bets to put money on.